Source: Eur Respir J 2016; 47:1864-1867
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Benfante Alida, Battaglia Salvatore, Principe Stefania, Di Mitri Chiara, Paternò Alessandra, Spatafora Mario, Scichilone Nicola. Asthmatics with high levels of serum surfactant protein D have more severe disease. Eur Respir J 2016; 47:1864-1867

Member's Comments

No comment yet.

Related content which might interest you: The relationhip between serum levels of Surfactant protein D in COPD exacerbation severity and mortality Source: International Congress 2018 – Biomarkers of COPD Year: 2018 COPD patients with more severe GOLD stages have higher serum cystatin C levels Source: Annual Congress 2012 - The smoking gun in COPD biology Year: 2012 Serum levels of IL-6 in adult patients with moderate to severe asthma. Source: International Congress 2017 – Novel mechanisms in asthma Year: 2017 Surfactant protein-A serum level is associated with disease control and hospitalisation in patients with bronchial asthma Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases Year: 2010 Plasma surfactant protein D (SP-D) and nutritive status in patients with COPD Source: Annual Congress 2013 –COPD treatment and others Year: 2013 High sensivity C reactive protein (HS-CRP) levels mark pulmonary and systemic inflammation in stable COPD Source: Eur Respir J 2006; 28: Suppl. 50, 337s Year: 2006 Serum surfactant protein D (SPD) as a specific marker for COPD Source: Annual Congress 2012 - COPD treatment and varia Year: 2012 Increased serum endotoxin levels as biomarker in acute exacerbations of COPD. Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Elevated levels of serum SP-A in chronic eosinophilic pneumonia Source: Eur Respir J 2001; 18: Suppl. 33, 409s Year: 2001 Serum vitamin D level is associated with emphysema progression in male patients with COPD Source: International Congress 2017 – Markers of COPD progression Year: 2017 Early stage asymptomatic (HRCT detectable) patients with IPF showed augmented serum surfactant protein D (SP-D) Source: Eur Respir J 2002; 20: Suppl. 38, 61s Year: 2002 Levels of serum amyloid A (SAA) and C-reactive protein (CRP) in stable COPD patients and its relationship with disease severity. Source: International Congress 2017 – COPD biomarkers Year: 2017 Increased CCL18 serum levels in patients with pulmonary fibrosis which reflect disease severity Source: Eur Respir J 2005; 26: Suppl. 49, 21s Year: 2005 Plasma surfactant protein A levels are increased in smokers but do not correlate with respiratory symptoms and airway obstruction Source: Annual Congress 2010 - COPD: phenotyping and monitoring Year: 2010 Low plasma CC16 levels in smokers are associated with a higher risk for chronic bronchitis Source: Eur Respir J 2015; 46: 1501-1503 Year: 2015 Serum surfactant protein D (SP-D) is a lung derived biomarker for COPD that is responsive to treatment with oral corticosteroids Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 COPD: Acute exacerbation (AE) rate and saturation in the patients with different plasma surfactant protein D (SP-D) level Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Relation of low serum lipid levels with coronary atherosclerosi in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 662s Year: 2006 Plasma levels of soluble RAGE are lower in COPD Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic Year: 2009 Elevated serum inflammatory markers in patients with stable COPD Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease Year: 2009